Early experience with the agents confirms findings from clinical trials
Despite advancements, care for this rare autoimmune disease is too complex to go it alone
Research avenues to keep an eye on in MS and NMOSD diagnostics and therapeutics
Large cohort study supports early consideration of aggressive therapy
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy